GlassScriptPhysician profile
Sonyo Shin
NPI 1124217971
$3,155.74
in general payments reported to CMS, 2019-2025
46 companies · $1,124 in 2025
The $1,124 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $197 · 2021: $108 · 2022: $211 · 2023: $26.63 · 2024: $437 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.35 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $244.77 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $237.13 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $206.66 | 2019-2025 | Keytruda, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $188.30 | 2019-2025 | Reblozyl |
| Astrazeneca Pharmaceuticals LP | $176.25 | 2019-2025 | Enhertu |
| Abbvie INC. | $158.87 | 2024-2025 | |
| Genentech USA, INC. | $149.95 | 2019-2025 | Itovebi, Tecentriq, Polivy |
| Astellas Pharma US INC | $149.10 | 2019-2025 | Vyloy |
| Gilead Sciences, INC. | $140.55 | 2019-2025 | Trodelvy |
| Ge Healthcare | $135.14 | 2022 | |
| Janssen Biotech, INC. | $125.91 | 2019-2025 | Rybrevant, Tecvayli |
| Pharmacosmos Therapeutics INC. | $125.74 | 2024 | Monoferric |
| Daiichi Sankyo INC. | $96.34 | 2022-2025 | Enhertu |
| Aveo Pharmaceuticals, INC. | $89.99 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $85.18 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonyo Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.